AI Assisted Personalized Legacy Program (Reflections: My Story) for Patients With Serious Illness

Mayo Clinic40 enrolled

Overview

The purpose of this study is to determine if it is feasible and acceptable to recruit for and deliver the AI Assisted Personalized Legacy Program intervention to patients with serious illness.

This study is an investigator-initiated, multi-site Mayo Clinic prospective minimal risk pilot study to determine feasibility and acceptability of an AI Assisted Personalized Legacy Program. The AI Assisted Personalized Legacy Program intervention is a brief, individualized psychotherapy that aims to relieve psycho-emotional and existential distress and improve the experiences of patients whose lives are impacted by serious illness. This therapy offers patients an opportunity to reflect on their life with a trained facilitator and share their thoughts and memories with family and other people in their life. The sessions are recorded and transcribed. The interventionist will work with patients to edit the document and provide a final legacy document for patient to keep and give to loved ones.

Study Type

INTERVENTIONAL

Allocation

Purpose

SUPPORTIVE_CARE

Masking

NONE

Enrollment

Conditions

Serious Illness Existential Distress

Interventions

AI Assisted Personalized Legacy ProgramBEHAVIORAL

AI Assisted Personalized Legacy Program will be facilitated by a clinician trained in legacy work.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Participant population: Adults with serious illness - defined as a health condition that carries a high risk of mortality Inclusion Criteria for patients: 1. Age ≥18 years 2. English fluency 3. Provide informed consent 4. Ability to complete questionnaire(s) by themselves or with assistance Exclusion Criteria: 1. Other psychological co-morbidities such as untreated schizophrenia, bipolar disease 2. Recent suicide attempt or psychiatric illness severe enough that hospitalization has been necessary in last 6 months 3. Active delirium 4. Advanced dementia 5. Participation in concurrent legacy offerings through the palliative care clinic

Locations (2)

Mayo Clinic

Phoenix, Arizona, United States

RECRUITING

Mayo Clinic

Rochester, Minnesota, United States

RECRUITING

Outcomes

Primary Outcomes

Feasibility Number

Study feasibility will be measured by the number of participants who enrolled and finished the study.

Time frame: 2 years

Acceptability

Acceptability, as measured by the 7-item Was it Worth It (WIWI Questionnaire).The questions are answered as either "yes, no, or uncertain," overall perception of quality of life change, overall perception of study experience, one open-ended feedback question, and an option to talk with someone about concerns. Positive responses indicate acceptability. Results are reported as individual items.

Time frame: 5-10 days post-delivery of the final legacy document

Central Contacts

Melissa Felt

CONTACT

507-255-4162 felt.melissa@mayo.edu

Deirdre Pachman, MD

CONTACT

507-293-9793 pachman.deirdre@mayo.edu

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.